CG
VBIV

Cutler Group’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Cutler Group’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-40
Closed – – 4334
2023
Q1 		$0 Sell
40
-10
-20% -$142 ﹤0.01% 4926
2022
Q4 		$0 Hold
50
– – ﹤0.01% 5437
2022
Q3 		$1K Hold
50
– – ﹤0.01% 4762
2022
Q2 		$1K Buy
50
+10
+25% +$340 ﹤0.01% 4801
2022
Q1 		$1K Hold
40
– – ﹤0.01% 5148
2021
Q4 		$2K Hold
40
– – ﹤0.01% 4874
2021
Q3 		$3K Hold
40
– – ﹤0.01% 4904
2021
Q2 		$4K Sell
40
-207
-84% -$20.2K ﹤0.01% 4668
2021
Q1 		$23K Buy
247
+230
+1,353% +$23.3K ﹤0.01% 3112
2020
Q4 		$1K Sell
17
-50
-75% -$4.26K ﹤0.01% 4649
2020
Q3 		$5K Sell
67
-10
-13% -$1.17K ﹤0.01% 3563
2020
Q2 		$7K Buy
77
+37
+93% +$2.04K ﹤0.01% 3136
2020
Q1 		$1K Buy
+40
New +$1.55K ﹤0.01% 3856

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cutler Group's VBIV Position: Q2 2023 in Review

Cutler Group sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 40 shares.

Cutler Group first reported a position in VBIV in Q1 2020 and held it in 13 quarters. The position peaked at $23K in Q1 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

  • Cutler Group reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
  • Cutler Group sold 40 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023.
  • Cutler Group first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2020 and held it in 13 quarters.
  • Cutler Group's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $23K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.